Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc.verified

NAVB

Price:

$0.000099999997

Market Cap:

$100.00

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages for a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (PET), gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. It...[Read more]

Industry

Biotechnology

IPO Date

1992-11-10

Stock Exchange

OTC

Ticker

NAVB

The ROE as of February 2026 (TTM) for Navidea Biopharmaceuticals, Inc. (NAVB) is 355.34%

According to Navidea Biopharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 355.34%. This represents a change of -427.68% compared to the average of -108.44% of the last 4 quarters.

Navidea Biopharmaceuticals, Inc. (NAVB) Historical ROE (quarterly & annually)

How has NAVB ROE performed in the past?

The mean historical ROE of Navidea Biopharmaceuticals, Inc. over the last ten years is 1.20%. The current 355.34% ROE has changed -70.49% with respect to the historical average. Over the past ten years (40 quarters), NAVB's ROE was at its highest in in the December 2021 quarter at 3.43%. The ROE was at its lowest in in the September 2020 quarter at -1706.73%.

Quarterly (TTM)
Annual

Average

1.20%

Median

149.89%

Minimum

-925.67%

Maximum

11.01%

Navidea Biopharmaceuticals, Inc. (NAVB) ROE by Quarter and Year

Discovering the peaks and valleys of Navidea Biopharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.04%

Maximum Annual ROE = 11.01%

Minimum Annual Increase = -1450.88%

Minimum Annual ROE = -925.67%

Quarterly (TTM)
Annual
YearROEChange
2022179.91%-98.37%
202111.01%-1450.88%
2020-814.96%-220.05%
2019678.88%-173.34%
2018-925.67%-240.55%
2017658.60%3.04%
201621.00%-58.62%
201550.76%-57.66%
2014119.87%-88.74%
20131.06%-48.67%

Navidea Biopharmaceuticals, Inc. (NAVB) Average ROE

How has NAVB ROE performed in the past?

The current ROE of Navidea Biopharmaceuticals, Inc. (NAVB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.46%

5-year avg

2.03%

10-year avg

1.20%

Navidea Biopharmaceuticals, Inc. (NAVB) ROE vs. Peers

How is NAVB’s ROE compared to its peers?

Navidea Biopharmaceuticals, Inc.’s ROE is less than Generex Biotechnology Corporation (216.76%), less than WPD Pharmaceuticals Inc. (15.48%), less than Nanomix Corporation (128.37%), less than NeonMind Biosciences Inc. (366.65%), less than Gelesis Holdings, Inc. (31.43%), less than MobileSmith, Inc. (225.88%), greater than Goodbody Health Limited (-34.66%), less than Gene Biotherapeutics, Inc. (12.69%), greater than MagForce AG (-33.92%), less than Acorda Therapeutics, Inc. (786.07%),

Build a custom stock screener for Navidea Biopharmaceuticals, Inc. (NAVB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Navidea Biopharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Navidea Biopharmaceuticals, Inc. (NAVB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Navidea Biopharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Navidea Biopharmaceuticals, Inc.'s ROE?

How is the ROE calculated for Navidea Biopharmaceuticals, Inc. (NAVB)?

What is the highest ROE for Navidea Biopharmaceuticals, Inc. (NAVB)?

What is the 3-year average ROE for Navidea Biopharmaceuticals, Inc. (NAVB)?

What is the 5-year average ROE for Navidea Biopharmaceuticals, Inc. (NAVB)?

How does the current ROE for Navidea Biopharmaceuticals, Inc. (NAVB) compare to its historical average?